nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC2—hematopoietic system—sarcoma	0.0275	0.0399	CbGeAlD
Dihydroxyaluminium—VDAC3—myometrium—sarcoma	0.0267	0.0387	CbGeAlD
Dihydroxyaluminium—VDAC2—connective tissue—sarcoma	0.0265	0.0384	CbGeAlD
Dihydroxyaluminium—VDAC1—myometrium—sarcoma	0.0254	0.0368	CbGeAlD
Dihydroxyaluminium—VDAC3—seminal vesicle—sarcoma	0.0241	0.035	CbGeAlD
Dihydroxyaluminium—VDAC2—skin of body—sarcoma	0.0239	0.0347	CbGeAlD
Dihydroxyaluminium—VDAC1—seminal vesicle—sarcoma	0.0229	0.0333	CbGeAlD
Dihydroxyaluminium—VDAC3—hematopoietic system—sarcoma	0.0229	0.0333	CbGeAlD
Dihydroxyaluminium—VDAC1—hematopoietic system—sarcoma	0.0218	0.0316	CbGeAlD
Dihydroxyaluminium—VDAC1—connective tissue—sarcoma	0.021	0.0305	CbGeAlD
Dihydroxyaluminium—VDAC2—uterus—sarcoma	0.0208	0.0302	CbGeAlD
Dihydroxyaluminium—VDAC3—smooth muscle tissue—sarcoma	0.0202	0.0293	CbGeAlD
Dihydroxyaluminium—VDAC3—skin of body—sarcoma	0.0199	0.0289	CbGeAlD
Dihydroxyaluminium—VDAC2—lymphoid tissue—sarcoma	0.0194	0.0281	CbGeAlD
Dihydroxyaluminium—VDAC1—smooth muscle tissue—sarcoma	0.0192	0.0279	CbGeAlD
Dihydroxyaluminium—VDAC1—skin of body—sarcoma	0.0189	0.0275	CbGeAlD
Dihydroxyaluminium—TNNC1—hematopoietic system—sarcoma	0.0187	0.0271	CbGeAlD
Dihydroxyaluminium—TNNC1—connective tissue—sarcoma	0.018	0.0261	CbGeAlD
Dihydroxyaluminium—VDAC3—cardiac atrium—sarcoma	0.0174	0.0253	CbGeAlD
Dihydroxyaluminium—VDAC3—uterus—sarcoma	0.0173	0.0251	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiac atrium—sarcoma	0.0165	0.024	CbGeAlD
Dihydroxyaluminium—VDAC1—uterus—sarcoma	0.0165	0.0239	CbGeAlD
Dihydroxyaluminium—VDAC1—lymphoid tissue—sarcoma	0.0153	0.0223	CbGeAlD
Dihydroxyaluminium—VDAC3—tendon—sarcoma	0.0152	0.022	CbGeAlD
Dihydroxyaluminium—VDAC2—testis—sarcoma	0.0151	0.0219	CbGeAlD
Dihydroxyaluminium—VDAC3—bone marrow—sarcoma	0.0147	0.0213	CbGeAlD
Dihydroxyaluminium—VDAC1—tendon—sarcoma	0.0144	0.0209	CbGeAlD
Dihydroxyaluminium—VDAC2—liver—sarcoma	0.0142	0.0207	CbGeAlD
Dihydroxyaluminium—TNNC1—cardiac atrium—sarcoma	0.0142	0.0206	CbGeAlD
Dihydroxyaluminium—VDAC1—bone marrow—sarcoma	0.014	0.0203	CbGeAlD
Dihydroxyaluminium—VDAC3—testis—sarcoma	0.0126	0.0182	CbGeAlD
Dihydroxyaluminium—TNNC1—tendon—sarcoma	0.0124	0.0179	CbGeAlD
Dihydroxyaluminium—VDAC1—testis—sarcoma	0.0119	0.0173	CbGeAlD
Dihydroxyaluminium—VDAC3—liver—sarcoma	0.0119	0.0172	CbGeAlD
Dihydroxyaluminium—VDAC1—liver—sarcoma	0.0113	0.0164	CbGeAlD
Dihydroxyaluminium—VDAC2—lymph node—sarcoma	0.0109	0.0159	CbGeAlD
Dihydroxyaluminium—TNNC1—testis—sarcoma	0.0102	0.0149	CbGeAlD
Dihydroxyaluminium—Encephalopathy—Thiotepa—sarcoma	0.0101	0.0325	CcSEcCtD
Dihydroxyaluminium—VDAC3—lymph node—sarcoma	0.0091	0.0132	CbGeAlD
Dihydroxyaluminium—VDAC1—lymph node—sarcoma	0.00866	0.0126	CbGeAlD
Dihydroxyaluminium—Extravasation—Thiotepa—sarcoma	0.00743	0.0239	CcSEcCtD
Dihydroxyaluminium—TNNC1—lymph node—sarcoma	0.00742	0.0108	CbGeAlD
Dihydroxyaluminium—Extravasation—Dactinomycin—sarcoma	0.00738	0.0237	CcSEcCtD
Dihydroxyaluminium—Extravasation—Vincristine—sarcoma	0.00659	0.0212	CcSEcCtD
Dihydroxyaluminium—Extravasation—Mitoxantrone—sarcoma	0.00642	0.0206	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Dactinomycin—sarcoma	0.00542	0.0174	CcSEcCtD
Dihydroxyaluminium—Extravasation—Etoposide—sarcoma	0.00534	0.0172	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Etoposide—sarcoma	0.0053	0.017	CcSEcCtD
Dihydroxyaluminium—Coma—Vincristine—sarcoma	0.00525	0.0169	CcSEcCtD
Dihydroxyaluminium—Venous thrombosis—Epirubicin—sarcoma	0.00484	0.0155	CcSEcCtD
Dihydroxyaluminium—Polyuria—Vincristine—sarcoma	0.00475	0.0153	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Mitoxantrone—sarcoma	0.00472	0.0152	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Thiotepa—sarcoma	0.00448	0.0144	CcSEcCtD
Dihydroxyaluminium—Venous thrombosis—Doxorubicin—sarcoma	0.00448	0.0144	CcSEcCtD
Dihydroxyaluminium—Dehydration—Thiotepa—sarcoma	0.00438	0.0141	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Vincristine—sarcoma	0.00419	0.0135	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Mitoxantrone—sarcoma	0.00408	0.0131	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Vincristine—sarcoma	0.00397	0.0128	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Etoposide—sarcoma	0.00392	0.0126	CcSEcCtD
Dihydroxyaluminium—Dehydration—Vincristine—sarcoma	0.00388	0.0125	CcSEcCtD
Dihydroxyaluminium—Dehydration—Mitoxantrone—sarcoma	0.00378	0.0121	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Epirubicin—sarcoma	0.00369	0.0119	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Doxorubicin—sarcoma	0.00341	0.011	CcSEcCtD
Dihydroxyaluminium—Extravasation—Epirubicin—sarcoma	0.00299	0.00962	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Epirubicin—sarcoma	0.00297	0.00955	CcSEcCtD
Dihydroxyaluminium—Chills—Thiotepa—sarcoma	0.00292	0.00939	CcSEcCtD
Dihydroxyaluminium—Chills—Dactinomycin—sarcoma	0.0029	0.00932	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Mitoxantrone—sarcoma	0.00282	0.00906	CcSEcCtD
Dihydroxyaluminium—Extravasation—Doxorubicin—sarcoma	0.00277	0.0089	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Doxorubicin—sarcoma	0.00275	0.00884	CcSEcCtD
Dihydroxyaluminium—Back pain—Thiotepa—sarcoma	0.00274	0.00881	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Thiotepa—sarcoma	0.00267	0.00859	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Epirubicin—sarcoma	0.00254	0.00815	CcSEcCtD
Dihydroxyaluminium—Chills—Mitoxantrone—sarcoma	0.00252	0.00811	CcSEcCtD
Dihydroxyaluminium—Convulsion—Thiotepa—sarcoma	0.00246	0.00789	CcSEcCtD
Dihydroxyaluminium—Back pain—Vincristine—sarcoma	0.00243	0.00781	CcSEcCtD
Dihydroxyaluminium—Coma—Epirubicin—sarcoma	0.00239	0.00767	CcSEcCtD
Dihydroxyaluminium—Back pain—Mitoxantrone—sarcoma	0.00237	0.00761	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Doxorubicin—sarcoma	0.00235	0.00754	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Mitoxantrone—sarcoma	0.00231	0.00741	CcSEcCtD
Dihydroxyaluminium—Infection—Thiotepa—sarcoma	0.0023	0.00739	CcSEcCtD
Dihydroxyaluminium—Oedema—Dactinomycin—sarcoma	0.0023	0.00738	CcSEcCtD
Dihydroxyaluminium—Infection—Dactinomycin—sarcoma	0.00228	0.00733	CcSEcCtD
Dihydroxyaluminium—Vertigo—Vincristine—sarcoma	0.00226	0.00726	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Thiotepa—sarcoma	0.00226	0.00726	CcSEcCtD
Dihydroxyaluminium—Coma—Doxorubicin—sarcoma	0.00221	0.00709	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Epirubicin—sarcoma	0.0022	0.00707	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Epirubicin—sarcoma	0.00219	0.00704	CcSEcCtD
Dihydroxyaluminium—Convulsion—Vincristine—sarcoma	0.00218	0.007	CcSEcCtD
Dihydroxyaluminium—Convulsion—Mitoxantrone—sarcoma	0.00212	0.00682	CcSEcCtD
Dihydroxyaluminium—Chills—Etoposide—sarcoma	0.0021	0.00675	CcSEcCtD
Dihydroxyaluminium—Oedema—Vincristine—sarcoma	0.00205	0.00659	CcSEcCtD
Dihydroxyaluminium—Infection—Vincristine—sarcoma	0.00204	0.00655	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Doxorubicin—sarcoma	0.00204	0.00654	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Doxorubicin—sarcoma	0.00203	0.00651	CcSEcCtD
Dihydroxyaluminium—Oedema—Mitoxantrone—sarcoma	0.002	0.00642	CcSEcCtD
Dihydroxyaluminium—Infection—Mitoxantrone—sarcoma	0.00198	0.00638	CcSEcCtD
Dihydroxyaluminium—Pain—Thiotepa—sarcoma	0.00198	0.00636	CcSEcCtD
Dihydroxyaluminium—Back pain—Etoposide—sarcoma	0.00197	0.00633	CcSEcCtD
Dihydroxyaluminium—Pain—Dactinomycin—sarcoma	0.00196	0.00631	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Mitoxantrone—sarcoma	0.00195	0.00627	CcSEcCtD
Dihydroxyaluminium—Hypotension—Vincristine—sarcoma	0.00192	0.00616	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Epirubicin—sarcoma	0.0019	0.00612	CcSEcCtD
Dihydroxyaluminium—Hypotension—Mitoxantrone—sarcoma	0.00187	0.006	CcSEcCtD
Dihydroxyaluminium—Urticaria—Thiotepa—sarcoma	0.00184	0.00591	CcSEcCtD
Dihydroxyaluminium—Vertigo—Etoposide—sarcoma	0.00183	0.00588	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Thiotepa—sarcoma	0.00183	0.00588	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dactinomycin—sarcoma	0.00181	0.00583	CcSEcCtD
Dihydroxyaluminium—Convulsion—Etoposide—sarcoma	0.00176	0.00567	CcSEcCtD
Dihydroxyaluminium—Dehydration—Epirubicin—sarcoma	0.00176	0.00566	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Doxorubicin—sarcoma	0.00176	0.00566	CcSEcCtD
Dihydroxyaluminium—Pain—Vincristine—sarcoma	0.00175	0.00564	CcSEcCtD
Dihydroxyaluminium—Pain—Mitoxantrone—sarcoma	0.00171	0.00549	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Thiotepa—sarcoma	0.0017	0.00548	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Dactinomycin—sarcoma	0.00169	0.00544	CcSEcCtD
Dihydroxyaluminium—Infection—Etoposide—sarcoma	0.00165	0.00531	CcSEcCtD
Dihydroxyaluminium—Dehydration—Doxorubicin—sarcoma	0.00163	0.00524	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Etoposide—sarcoma	0.00162	0.00521	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Vincristine—sarcoma	0.00162	0.00521	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Epirubicin—sarcoma	0.0016	0.00513	CcSEcCtD
Dihydroxyaluminium—Urticaria—Mitoxantrone—sarcoma	0.00159	0.0051	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Thiotepa—sarcoma	0.00158	0.00509	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Mitoxantrone—sarcoma	0.00158	0.00508	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dactinomycin—sarcoma	0.00157	0.00505	CcSEcCtD
Dihydroxyaluminium—Hypotension—Etoposide—sarcoma	0.00155	0.00499	CcSEcCtD
Dihydroxyaluminium—Dizziness—Thiotepa—sarcoma	0.00153	0.00492	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Vincristine—sarcoma	0.00151	0.00486	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Doxorubicin—sarcoma	0.00148	0.00475	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Mitoxantrone—sarcoma	0.00147	0.00473	CcSEcCtD
Dihydroxyaluminium—Vomiting—Thiotepa—sarcoma	0.00147	0.00473	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dactinomycin—sarcoma	0.00146	0.00469	CcSEcCtD
Dihydroxyaluminium—Pain—Etoposide—sarcoma	0.00142	0.00457	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Vincristine—sarcoma	0.0014	0.00451	CcSEcCtD
Dihydroxyaluminium—Nausea—Thiotepa—sarcoma	0.00137	0.00442	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Mitoxantrone—sarcoma	0.00137	0.00439	CcSEcCtD
Dihydroxyaluminium—Nausea—Dactinomycin—sarcoma	0.00136	0.00438	CcSEcCtD
Dihydroxyaluminium—Dizziness—Vincristine—sarcoma	0.00136	0.00436	CcSEcCtD
Dihydroxyaluminium—Urticaria—Etoposide—sarcoma	0.00132	0.00424	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Epirubicin—sarcoma	0.00131	0.00422	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Etoposide—sarcoma	0.00131	0.00422	CcSEcCtD
Dihydroxyaluminium—Vomiting—Vincristine—sarcoma	0.0013	0.00419	CcSEcCtD
Dihydroxyaluminium—Vomiting—Mitoxantrone—sarcoma	0.00127	0.00408	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Epirubicin—sarcoma	0.00126	0.00406	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Etoposide—sarcoma	0.00122	0.00393	CcSEcCtD
Dihydroxyaluminium—Nausea—Vincristine—sarcoma	0.00122	0.00392	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Doxorubicin—sarcoma	0.00122	0.00391	CcSEcCtD
Dihydroxyaluminium—Nausea—Mitoxantrone—sarcoma	0.00119	0.00381	CcSEcCtD
Dihydroxyaluminium—Chills—Epirubicin—sarcoma	0.00118	0.00378	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Doxorubicin—sarcoma	0.00117	0.00376	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Etoposide—sarcoma	0.00114	0.00365	CcSEcCtD
Dihydroxyaluminium—Back pain—Epirubicin—sarcoma	0.0011	0.00355	CcSEcCtD
Dihydroxyaluminium—Dizziness—Etoposide—sarcoma	0.0011	0.00353	CcSEcCtD
Dihydroxyaluminium—Chills—Doxorubicin—sarcoma	0.00109	0.0035	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Epirubicin—sarcoma	0.00108	0.00346	CcSEcCtD
Dihydroxyaluminium—Vomiting—Etoposide—sarcoma	0.00106	0.0034	CcSEcCtD
Dihydroxyaluminium—Vertigo—Epirubicin—sarcoma	0.00103	0.0033	CcSEcCtD
Dihydroxyaluminium—Back pain—Doxorubicin—sarcoma	0.00102	0.00328	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Doxorubicin—sarcoma	0.000995	0.0032	CcSEcCtD
Dihydroxyaluminium—Convulsion—Epirubicin—sarcoma	0.000989	0.00318	CcSEcCtD
Dihydroxyaluminium—Nausea—Etoposide—sarcoma	0.000987	0.00317	CcSEcCtD
Dihydroxyaluminium—Vertigo—Doxorubicin—sarcoma	0.000949	0.00305	CcSEcCtD
Dihydroxyaluminium—Oedema—Epirubicin—sarcoma	0.000931	0.00299	CcSEcCtD
Dihydroxyaluminium—Infection—Epirubicin—sarcoma	0.000925	0.00297	CcSEcCtD
Dihydroxyaluminium—Convulsion—Doxorubicin—sarcoma	0.000915	0.00294	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Epirubicin—sarcoma	0.000909	0.00292	CcSEcCtD
Dihydroxyaluminium—Hypotension—Epirubicin—sarcoma	0.00087	0.0028	CcSEcCtD
Dihydroxyaluminium—Oedema—Doxorubicin—sarcoma	0.000862	0.00277	CcSEcCtD
Dihydroxyaluminium—Infection—Doxorubicin—sarcoma	0.000856	0.00275	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Doxorubicin—sarcoma	0.000841	0.0027	CcSEcCtD
Dihydroxyaluminium—Hypotension—Doxorubicin—sarcoma	0.000805	0.00259	CcSEcCtD
Dihydroxyaluminium—Pain—Epirubicin—sarcoma	0.000797	0.00256	CcSEcCtD
Dihydroxyaluminium—Urticaria—Epirubicin—sarcoma	0.00074	0.00238	CcSEcCtD
Dihydroxyaluminium—Pain—Doxorubicin—sarcoma	0.000737	0.00237	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Epirubicin—sarcoma	0.000736	0.00237	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Epirubicin—sarcoma	0.000686	0.00221	CcSEcCtD
Dihydroxyaluminium—Urticaria—Doxorubicin—sarcoma	0.000685	0.0022	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Doxorubicin—sarcoma	0.000681	0.00219	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Epirubicin—sarcoma	0.000637	0.00205	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Doxorubicin—sarcoma	0.000635	0.00204	CcSEcCtD
Dihydroxyaluminium—Dizziness—Epirubicin—sarcoma	0.000616	0.00198	CcSEcCtD
Dihydroxyaluminium—Vomiting—Epirubicin—sarcoma	0.000592	0.0019	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Doxorubicin—sarcoma	0.00059	0.0019	CcSEcCtD
Dihydroxyaluminium—Dizziness—Doxorubicin—sarcoma	0.00057	0.00183	CcSEcCtD
Dihydroxyaluminium—Nausea—Epirubicin—sarcoma	0.000553	0.00178	CcSEcCtD
Dihydroxyaluminium—Vomiting—Doxorubicin—sarcoma	0.000548	0.00176	CcSEcCtD
Dihydroxyaluminium—Nausea—Doxorubicin—sarcoma	0.000512	0.00165	CcSEcCtD
